201 related articles for article (PubMed ID: 9924211)
1. Mortality and causes of death in a Swedish series of systemic sclerosis patients.
Hesselstrand R; Scheja A; Akesson A
Ann Rheum Dis; 1998 Nov; 57(11):682-6. PubMed ID: 9924211
[TBL] [Abstract][Full Text] [Related]
2. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
Joven BE; Almodovar R; Carmona L; Carreira PE
Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
[TBL] [Abstract][Full Text] [Related]
3. Oral cyclophosphamide for active scleroderma lung disease: a decision analysis.
Khanna D; Furst DE; Clements PJ; Tashkin DP; Eckman MH
Med Decis Making; 2008; 28(6):926-37. PubMed ID: 18443209
[TBL] [Abstract][Full Text] [Related]
4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
5. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
[TBL] [Abstract][Full Text] [Related]
6. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
Hoffmann-Vold AM; Molberg Ø; Midtvedt Ø; Garen T; Gran JT
J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316
[TBL] [Abstract][Full Text] [Related]
7. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.
Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N
Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis and malignancy.
Sargin G; Senturk T; Cildag S
Int J Rheum Dis; 2018 May; 21(5):1093-1097. PubMed ID: 29673080
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.
Shenoy PD; Bavaliya M; Sashidharan S; Nalianda K; Sreenath S
Arthritis Res Ther; 2016 Jun; 18(1):123. PubMed ID: 27255492
[TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
[TBL] [Abstract][Full Text] [Related]
11. Changes in causes of death in systemic sclerosis, 1972-2002.
Steen VD; Medsger TA
Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
[TBL] [Abstract][Full Text] [Related]
12. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma).
Jacobsen S; Halberg P; Ullman S
Br J Rheumatol; 1998 Jul; 37(7):750-5. PubMed ID: 9714351
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
[TBL] [Abstract][Full Text] [Related]
14. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
Iudici M; Cuomo G; Vettori S; Bocchino M; Sanduzzi Zamparelli A; Cappabianca S; Valentini G
Semin Arthritis Rheum; 2015 Feb; 44(4):437-44. PubMed ID: 25282395
[TBL] [Abstract][Full Text] [Related]
15. A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide.
Sabnani I; Zucker MJ; Rosenstein ED; Baran DA; Arroyo LH; Tsang P; Zubair M; Rivera V
Rheumatology (Oxford); 2009 Jan; 48(1):49-52. PubMed ID: 18815156
[TBL] [Abstract][Full Text] [Related]
16. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
[TBL] [Abstract][Full Text] [Related]
17. [Heart involvement in systemic sclerosis: analysis of four cases].
Wielosz E; Borys O; Błaszczak P; Majdan M
Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
Adler S; Huscher D; Siegert E; Allanore Y; Czirják L; DelGaldo F; Denton CP; Distler O; Frerix M; Matucci-Cerinic M; Mueller-Ladner U; Tarner IH; Valentini G; Walker UA; Villiger PM; Riemekasten G;
Arthritis Res Ther; 2018 Jan; 20(1):17. PubMed ID: 29382380
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience.
Balbir-Gurman A; Yigla M; Guralnik L; Hardak E; Solomonov A; Rozin AP; Toledano K; Dagan A; Bishara R; Markovits D; Nahir MA; Braun-Moscovici Y
Isr Med Assoc J; 2015 Mar; 17(3):150-6. PubMed ID: 25946765
[TBL] [Abstract][Full Text] [Related]
20. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.
Sampaio-Barros PD; Bortoluzzo AB; Marangoni RG; Rocha LF; Del Rio AP; Samara AM; Yoshinari NH; Marques-Neto JF
J Rheumatol; 2012 Oct; 39(10):1971-8. PubMed ID: 22896025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
